Salarius PharmaceuticalsSalarius Pharmaceuticals

Share on: 
Website: Salarius Pharmaceuticals
Description: 

Salarius Pharmaceuticals is an emerging biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Salarius' lead molecule, Seclidemstat, is a reversible LSD1 inhibitor. Seclidemstat inhibits LSD1's demethylation and scaffolding properties.

Location(s): 
Houston TX
United States